Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?

PURPOSE: Despite evidence supporting at least five years of endocrine therapy for early breast cancer, many women discontinue therapy early. We investigated the impact of initial therapy type and specific comorbidities on discontinuation of endocrine therapy in clinical practice. METHODS: We identif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kemp, Anna, Preen, David B, Saunders, Christobel, Boyle, Frances, Bulsara, Max, Malacova, Eva, Roughead, Elizabeth E
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058005/
https://ncbi.nlm.nih.gov/pubmed/24936397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-282
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares